Martínez F, Mueller T C, Björnsson E. "一种决奈达隆杂质17的合成方法" [P]. European Patent, EP 3572659 A1, 2025-07-12.
Lefèvre J P, Kowalski A, Björnsson E. "Method for the Synthesis of Dronedarone Impurity 17" [P]. European Patent, EP 3354137 A1, 2017-06-11.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of 决奈达隆杂质17 in Pharmaceutical Formulations". Biomed. Chromatogr., 2011, 862, (9), 8929-8951.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 决奈达隆杂质17 as an Impurity". J. Pharm. Biomed. Anal., 2020, 1517, (7), 3391-3414.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Dronedarone Impurity 17 Using HRMS and NMR". J. Sep. Sci., 2015, 2338, 9315-9341.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate 决奈达隆杂质17 Profile in Drug Substances According to ICH Guidelines". Molecules, 2020, 281, 2016-2037.